- Vouliez-vous dire
- carcinoma
Résultats de la recherche - 2 results
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
adenocarcinoma in situ associated with HPV16 /18 infection in young women who were not initially infected with hrHPV or HPV16 /18. Vaccine efficacy was lower when all women regardless of HPV DNA status at ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
re-infection, against cervical cancer and its precursors (high-grade CIN (grade 2 or grade 3), adenocarcinoma in situ) in women previously not exposed to HPV infection (negative at enrolment for both HPV DNA and ...